Department of diagnostic and interventional imaging, Hôpital Haut-Lévêque, university hospital of Bordeaux, CHU de Bordeaux, 1, avenue de Magellan, 33604 Pessac cedex, France.
Department of diagnostic and interventional imaging, university hospital of Angers, 49933 Angers, France.
Diagn Interv Imaging. 2017 May;98(5):379-391. doi: 10.1016/j.diii.2017.01.014. Epub 2017 Apr 5.
Imaging is essential for the successful management of patients with or at risk of developing hepatocellular carcinoma (HCC). If ultrasound remains the key screening modality, computed tomography and magnetic resonance imaging (MRI) can play a major role in the characterization and noninvasive diagnosis of nodules in patients at risk of developing HCC. Each technique has succeeded in adapting to the wide histological spectrum of focal liver lesions. In this review, we discuss recent advancements in imaging techniques and evaluation - notably diffusion-weighted imaging, contrast-enhanced ultrasound, and liver-specific MRI contrast agents - as well as their addition to international guidelines and reporting systems such as the Liver imaging reporting and data system (LI-RADS).
影像学对于成功管理肝细胞癌（HCC）患者或有风险发展为 HCC 的患者至关重要。如果超声仍然是主要的筛查方式，那么计算机断层扫描和磁共振成像（MRI）可以在高危 HCC 患者的结节特征和非侵入性诊断中发挥重要作用。每种技术都成功地适应了肝脏局灶性病变的广泛组织学谱。在这篇综述中，我们讨论了影像学技术的最新进展和评估——特别是扩散加权成像、超声造影以及肝脏特异性 MRI 对比剂——以及它们在国际指南和报告系统中的应用，如肝脏成像报告和数据系统（LI-RADS）。
